Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suchy, S. F.
Right arrow Articles by Wolf, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suchy, S. F.
Right arrow Articles by Wolf, B.
NEUROLOGY 1985;35:1510
© 1985 American Academy of Neurology

Neurologic symptoms of biotinidase deficiency

Possible explanation

Sharon F. Suchy, PhD, Julie Secor McVoy, BS and Barry Wolf, MD, PhD

From the Departments ot Human Genetics and Pediatrics, Medical College of Virginia, Richmond, VA.

We found that the activity of biotinidase is much lower in human and rat brain or human CSF than in serum or other tissues that have biotin-dependent carboxylase activity. The brain seems to be unable to recycle biotin and depends on biotin transferred across the blood-brain barrier. The biotin-deficient state that results from an inherited lack of biotinidase results in a moderate decrease in brain pyruvate carboxylase activity. This is followed by more severe accumulation of lactate in brain than in other organs, which may explain why affected children have neurologic symptoms before many peripheral features.

Address currespondence and reprint requests to Dr. Wolf. Department of Human Genetics. Medical College of Virginia, PO Box 33, MCV Station, Richmond, VA 23298.

Supported by grants from The National Institutes of Health (AM 25675 and AM 33022) and from the National Foundation-March of Dimes (6–342). This is paper #250 from the Department of Human Genetics of the Medical College of Virginia.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Perez-Monjaras, R. Cervantes-Roldan, I. Meneses-Morales, R. A. Gravel, S. Reyes-Carmona, S. Solorzano-Vargas, A. Gonzalez-Noriega, and A. Leon-Del-Rio
Impaired Biotinidase Activity Disrupts Holocarboxylase Synthetase Expression in Late Onset Multiple Carboxylase Deficiency
J. Biol. Chem., December 5, 2008; 283(49): 34150 - 34158.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. C. Rathman, R. K. Blanchard, L. Badinga, J. F. Gregory III, S. Eisenschenk, and R. J. McMahon
Dietary Carbamazepine Administration Decreases Liver Pyruvate Carboxylase Activity and Biotinylation by Decreasing Protein and mRNA Expression in Rats
J. Nutr., July 1, 2003; 133(7): 2119 - 2124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.